tiprankstipranks
Trending News
More News >
EyePoint completes enrollment in Phase 3 LUGANO trial of DURAVYU
PremiumThe FlyEyePoint completes enrollment in Phase 3 LUGANO trial of DURAVYU
1M ago
EyePoint price target lowered to $26 from $30 at Mizuho
Premium
The Fly
EyePoint price target lowered to $26 from $30 at Mizuho
2M ago
EyePoint reports inducement grants under NASDAQ listing rule
Premium
The Fly
EyePoint reports inducement grants under NASDAQ listing rule
2M ago
EyePoint Pharmaceuticals: Promising Clinical Progress and Strong Financial Position Justify Buy Rating
PremiumRatingsEyePoint Pharmaceuticals: Promising Clinical Progress and Strong Financial Position Justify Buy Rating
4M ago
EyePoint Pharmaceuticals Reports 2024 Financial Results
Premium
Company Announcements
EyePoint Pharmaceuticals Reports 2024 Financial Results
4M ago
EyePoint reports Q4 EPS (64c), consensus (48c)
Premium
The Fly
EyePoint reports Q4 EPS (64c), consensus (48c)
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100